Natural Biocon (India) Limited (BOM:543207)

Natural Biocon (India) Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	40	83.48	135.34	12.54	4.82	1.32
Revenue Growth (YoY)	-71.72%	-38.32%	978.97%	160.34%	265.24%	-
Cost of Revenue	35.55	73.94	126.69	8.79	2.88	0.89
Gross Profit	4.45	9.54	8.65	3.75	1.94	0.43
Selling, General & Admin	4.35	4.54	3.51	0.81	0.28	0.14
Other Operating Expenses	3.42	4.39	2.88	0.46	0.78	0.24
Operating Expenses	7.8	8.94	6.38	1.27	1.06	0.39
Operating Income	-3.35	0.61	2.26	2.48	0.89	0.04
Other Non Operating Income (Expenses)	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Pretax Income	-3.36	0.6	2.25	2.47	0.88	0.04
Income Tax Expense	0.15	0.15	0.73	0.68	0.22	0.01
Net Income	-3.51	0.45	1.53	1.79	0.66	0.03
Net Income to Common	-3.51	0.45	1.53	1.79	0.66	0.03
Net Income Growth	-	-70.77%	-14.77%	171.77%	2296.71%	-
Shares Outstanding (Basic)	21	21	11	11	11	11
Shares Outstanding (Diluted)	21	21	11	11	11	11
Shares Change (YoY)	77.76%	84.47%	-	-	-	-
EPS (Basic)	-0.17	0.02	0.13	0.16	0.06	0.00
EPS (Diluted)	-0.17	0.02	0.13	0.16	0.06	0.00
EPS Growth	-	-84.62%	-17.45%	171.77%	2297.39%	-
Gross Margin	11.12%	11.43%	6.39%	29.93%	40.33%	32.71%
Operating Margin	-8.39%	0.73%	1.67%	19.79%	18.41%	3.23%
Profit Margin	-8.79%	0.53%	1.13%	14.28%	13.68%	2.08%
EBITDA	-	0.61	-	-	-	-
EBITDA Margin	-	0.73%	-	-	-	-
D&A For EBITDA	-	0.01	-	-	-	-
EBIT	-3.35	0.61	2.26	2.48	0.89	0.04
EBIT Margin	-8.39%	0.73%	1.67%	19.79%	18.41%	3.23%
Effective Tax Rate	-	25.16%	32.24%	27.50%	25.03%	25.00%
Revenue as Reported	40	83.48	135.34	12.54	4.82	1.32
Advertising Expenses	-	0.02	0.01	-	0.02	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.